StockNews.com started coverage on shares of Oxbridge Re (NASDAQ:OXBR – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the insurance provider’s stock.
Oxbridge Re Stock Performance
Shares of NASDAQ OXBR opened at $4.32 on Thursday. The firm’s fifty day moving average is $3.61 and its two-hundred day moving average is $2.93. Oxbridge Re has a 52-week low of $0.87 and a 52-week high of $4.96. The company has a market cap of $26.09 million, a P/E ratio of -5.14 and a beta of 0.93.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Oxbridge Re stock. Geode Capital Management LLC lifted its stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 3.3% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 129,294 shares of the insurance provider’s stock after purchasing an additional 4,141 shares during the quarter. Geode Capital Management LLC owned about 2.14% of Oxbridge Re worth $359,000 at the end of the most recent reporting period. 5.64% of the stock is currently owned by institutional investors and hedge funds.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
Read More
- Five stocks we like better than Oxbridge Re
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.